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Concise statement: Multivariate methods (extending the range of addiction traits and 
including endophenotypes) and gene functional studies are needed to understand the 
genetic correlation between cognitive ability and risk of substance misuse. Such studies 
would enable us to better distinguish between models of biological pleiotropy and mediated 
pleiotropy. 
 
 
 
  
Latvala et al. (2016) use three diverse family designs to provide evidence for a largely 
genetic relationship between early cognitive ability and risk of substance misuse. Their 
finding is in line with the rapidly growing molecular genetic literature which supports an 
overlap of common genetic variants influencing cognitive ability and a host of psychiatric 
and physical disorders (1, 2). However, the basis of this genetic association remains 
speculative. The two main competing hypotheses are: 1) biological pleiotropy, where the 
same genes have direct effects on each of the correlated traits—cognitive ability and 
substance misuse—through the same or different biological pathways, and 2) mediated 
pleiotropy, where genes directly influence one trait and this trait influences the second trait 
(3).  
In a model of biological pleiotropy one might hypothesise that genes influencing executive 
functioning processes, such as response inhibition, could be candidates for common genetic 
effects because these measure have been phenotypically associated with cognitive abilities 
(4) and alcohol/illicit drug use (5). One strategy then would be to focus on endophenotypes 
of addiction, which are arguably easier to map in terms of biology than the addiction 
endpoint and are less likely to be direct outcomes of cognitive ability; one might instead 
consider them components of cognitive ability, which could fit with a model of biological 
pleiotropy. Ultimately, functional studies of relevant candidate genes are needed to 
establish mechanism and thus the likelihood of any individual gene having direct effects on 
both cognitive ability and substance misuse. Given that Latvala et al. (2016) tested a 
prospective relationship between cognitive ability in young adulthood and later substance 
misuse, a mediated pleiotropy model should expect the causal direction to be from 
cognitive ability to substance misuse. This could function via a host of factors, including 
increased health awareness, internal locus of control, resilience, and positive coping 
strategies that might be facilitated by better cognitive processing capacities . The direction of 
causation between variables can be explicitly tested in twin (6) and Mendelian 
Randomisation (7) studies assuming key assumptions are met. Such studies, coupled with 
genetically informative longitudinal studies, will provide further evidence for a particular 
causal direction. The inclusion of multiple endophenotypes of addiction within a 
multivariate longitudinal framework has the capacity to increase the reliability and the 
relations between variables in the analysis  (see 8). 
Another avenue of research to explore the cognitive ability- substance misuse genetic 
relationship is to focus on other forms of addiction—both physiological and behavioural. A 
substance such as caffeine could be particularly informative because it will be subject to less 
confounding from socio-economic factors, it has fewer negative effects on physical health 
than alcohol and illicit substances, and may even enhance cognitive ability (e.g., protection 
against dementia, 9)—so indeed one might observe a positive genetic correlation. 
Behavioural addictions such as gambling and internet gaming can tell us whether the 
genetic correlation between cognitive ability and substance misuse is limited to substances 
with physiological effects, or psychological effects, too. Perhaps these relationships are 
mediated to a greater extent by the environment; would we uncover the same positive 
nonshared environmental correlation reported by Latvala et al. (2016) for cognitive ability 
and substance misuse? The positive nonshared environmental correlation is certainly an 
interesting finding, could it be related to the personality trait openness to experience with 
which cognitive ability positively correlates. This trait shows a large contribution of variance 
from the nonshared environment, although in adolescence this is largely independent of 
cognitive abilities (10). There is some evidence which shows that people who are more 
open-minded, liberal and willing to try new experiences are more likely to use some types of 
illicit drugs (11). Comparing the environmental covariance between cognitive ability with 
licit and illicit drug use would help evaluate the strength of such a hypothesis. Latvala et al. 
(2016) used a combined index of alcohol and illicit drugs  in their genetic analysis, but their 
phenotypic analysis showed a stronger association between cognitive ability and drug-
related than alcohol-related medical events; differences in their constituent genetic and 
environmental variance components (and covariance with cognitive ability) might also exist. 
To further investigate environmental factors, family designs, such as those used by Latvala 
et al. (2016)  are needed in which cognitive ability and multiple substance use and addiction 
measures have been sampled; such designs are typically rare but would be valuable to 
establish. Genetic correlations, on the other hand, can be estimated using genome-wide 
association results of the measures of interest from independent samples , thus bypassing 
the need for multiple measures to be collected in a single sample. Large genome-wide 
studies of cognitive ability (e.g., 12) and some substance use variables (e.g., caffeine, 13) are 
currently available with others fast following suit. This linkage disequilibrium regression 
method for establishing genetic correlation will complement family designs by confirming 
how much shared genetic variance is due to common genetic variation as opposed to rare 
and/or structural variants. 
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